Regulatory context
Regulatory context; not efficacy evidence
No matched controlled human efficacy study of the exact supplier preparation was verified.
Reported findings. Background context only. Matched evidence for the exact marketed formulation is not established by this reference.
Nonresponse. Nonresponse frequency not established in this excerpt.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. Evidence for another ecdysteroid cannot automatically be attributed to turkesterone.
Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.
Read original source ↗Editorial review 2026-10-09. Clinician review pending.
Human trial
The Effects of Multiple Acute Turkesterone Doses on Indirect Measures of Hypertrophy and Metabolic Measures: A Preliminary Investigation.
11 healthy men; acute single-blind counterbalanced study.
Reported findings. Investigators assessed IGF-1, resting metabolism and substrate use.
Nonresponse. No significant IGF-1, resting-metabolic-rate or substrate-use effects.
Harms. Short-term gastrointestinal/hemodynamic tolerability reported; no long-term safety conclusion.
Limits. Very small acute study does not establish muscle gains or every commercial preparation’s effects.
Preparation: Oral Double Wood preparation; other products and extract purity not assumed equivalent. Route: oral
Read original source ↗Editorial review 2026-10-09. Clinician review pending.